X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (40) 40
humans (35) 35
index medicus (28) 28
cancer (21) 21
female (18) 18
male (18) 18
middle aged (17) 17
aged (14) 14
chemotherapy (12) 12
life sciences (12) 12
adult (11) 11
antineoplastic agents - therapeutic use (11) 11
antineoplastic agents - adverse effects (10) 10
immunology (9) 9
kidney neoplasms - drug therapy (9) 9
metastasis (9) 9
treatment outcome (9) 9
carcinoma, renal cell (8) 8
carcinoma, renal cell - drug therapy (8) 8
aged, 80 and over (7) 7
antineoplastic agents - administration & dosage (7) 7
neoplasm metastasis (7) 7
pharmacology & pharmacy (7) 7
renal cell carcinoma (7) 7
sunitinib (7) 7
survival (7) 7
disease-free survival (6) 6
docetaxel (6) 6
everolimus (6) 6
retrospective studies (6) 6
care and treatment (5) 5
drug therapy (5) 5
kidney neoplasms - pathology (5) 5
metastases (5) 5
patients (5) 5
prospective studies (5) 5
prostate cancer (5) 5
prostatic neoplasms - drug therapy (5) 5
urology & nephrology (5) 5
angiogenesis inhibitors - therapeutic use (4) 4
antineoplastic agents (4) 4
antineoplastic combined chemotherapy protocols - administration & dosage (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
breast neoplasms - drug therapy (4) 4
cabazitaxel (4) 4
cancer patients (4) 4
clinical trials (4) 4
drug administration schedule (4) 4
enzalutamide (4) 4
management (4) 4
medicine & public health (4) 4
mtor (4) 4
nephrectomy (4) 4
phase-ii trial (4) 4
phase-iii trial (4) 4
prognosis (4) 4
therapy (4) 4
toxicity (4) 4
analysis (3) 3
angiogenesis (3) 3
animals (3) 3
antineoplastic agents - pharmacokinetics (3) 3
antineoplastic combined chemotherapy protocols (3) 3
axitinib (3) 3
breast cancer (3) 3
cancer therapies (3) 3
carcinoma, renal cell - mortality (3) 3
carcinoma, renal cell - pathology (3) 3
carcinoma, renal cell - secondary (3) 3
chemotherapy, adjuvant (3) 3
cisplatin (3) 3
clear cell-type renal cell carcinoma (3) 3
disease progression (3) 3
double-blind (3) 3
drug resistance, neoplasm (3) 3
france (3) 3
hematology, oncology and palliative medicine (3) 3
immunotherapy (3) 3
interferon-alpha (3) 3
kidney neoplasms - mortality (3) 3
metastatic breast cancer (3) 3
metastatic breast-cancer (3) 3
mitoxantrone plus prednisone (3) 3
neoplasms - drug therapy (3) 3
neoplasms. tumors. oncology. including cancer and carcinogens (3) 3
neutropenia - chemically induced (3) 3
open-label (3) 3
patient outcomes (3) 3
pharmacokinetic (3) 3
pharmacokinetics (3) 3
phase-ii (3) 3
prostatic neoplasms - pathology (3) 3
prostatic neoplasms, castration-resistant - drug therapy (3) 3
prostatic neoplasms, castration-resistant - pathology (3) 3
protein kinase inhibitors - adverse effects (3) 3
protein kinase inhibitors - therapeutic use (3) 3
quality of life (3) 3
randomized controlled trials as topic (3) 3
randomized-trial (3) 3
research (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 08/2018, Volume 379, Issue 5, pp. 417 - 427
Journal Article
Bulletin du Cancer, ISSN 0007-4551, 11/2018, Volume 105, Issue 11, pp. 981 - 984
Journal Article
Health and Quality of Life Outcomes, ISSN 1477-7525, 02/2019, Volume 17, Issue 1, pp. 25 - 25
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2016, Volume 34, Issue 25, pp. 3005 - 3013
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 06/2017, Volume 79, Issue 6, pp. 1273 - 1276
Journal Article
Bulletin du Cancer, ISSN 0007-4551, 12/2018, Volume 105, pp. S219 - S220
New trends and perspectives in renal cell cancer: Š 
Journal Article
Bulletin du Cancer, ISSN 0007-4551, 10/2018, Volume 105, Issue 10, pp. 944 - 954
Genetic instability is one part of the oncogenic process. Gene mutations involved in DNA repair mechanisms can promote this genetic instability and participate... 
BRCA | Platinum | ATM | PARP | DNA repair | Prostate cancer
Journal Article
World Journal of Urology, ISSN 0724-4983, 3/2018, Volume 36, Issue 3, pp. 427 - 433
To compare the oncological outcomes of testicle-sparing surgery (TSS) and radical orchiectomy (RO) in patients with Leydig cell tumor (LCT) of the testis.A... 
Nephrology | Medicine & Public Health | Leydig cell tumor | Radical orchiectomy | Oncology | Testicle-sparing surgery | Urology | THERAPY | UROLOGY & NEPHROLOGY | TERM-FOLLOW-UP | EXPERIENCE | CANCER | FROZEN-SECTION EXAMINATION | FEATURES | Demography | Cell survival | Patients | Surgery | Tumors | Metastases | Index Medicus
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 05/2018, Volume 36, Issue 15, pp. 10029 - 10029
Conference Proceeding
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 03/2015, Volume 33, Issue 7, pp. 488 - 488
Conference Proceeding
Trials, ISSN 1745-6215, 04/2018, Volume 19, Issue 1, pp. 221 - 221
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.